Anti-tumor immunity activated by radiofrequency ablation combined with immuno-stimulant agent for rabbit VX2 tumor model
Project/Area Number |
21791208
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Single-year Grants |
Research Field |
Radiation science
|
Research Institution | Osaka City University |
Principal Investigator |
OKUMA Tomohisa Osaka City University, 大学院・医学研究科, 研究員 (50445029)
|
Research Collaborator |
HAMAMOTO Shinichi 大阪市立大学, 大学院・医学研究科, 大学院生
KAGEYAMA Ken 大阪市立大学, 大学院・医学研究科, 大学院生
YAMAMOTO Akira 大阪市立大学, 大学院・医学研究科, 講師 (60419695)
MATSUOKA Toshiyuki 大阪市立大学, 大学院・医学研究科, 准教授 (40295697)
|
Project Period (FY) |
2009 – 2010
|
Project Status |
Completed (Fiscal Year 2010)
|
Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2010: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2009: ¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
|
Keywords | 画像診断学(含放射線診断学、核医学) / ラジオ波凝固 / 実験腫瘍 / 免疫賦活 |
Research Abstract |
To evaluate anti-tumor immunity activated by radiofrequency ablation combined with immuno-stimulant agent, we examined end-point survival of combination therapy for rabbit VX2 tumor model.
|
Report
(3 results)
Research Products
(4 results)